No filters available. Try clearing your other selections.
FASENRA is indicated for the add-on maintenance treatment of adult and pediatric patients aged 6 years and older with severe asthma, and with an eosinophilic phenotype. FASENRA is not for the relief of acute bronchospasm or status asthmaticus.
